Modern Diagnostic & Research Centre traded at Rs 96 on the BSE, a premium of 6.67% compared with the issue price of Rs 90.
IPOs need to be restructured in a way that they support capital formation, not fund promoters’ exits like in the current ...
China's biotech revival is pushing up prices of laboratory monkeys used in drug testing, as renewed R&D activity collides ...
Next week will see one public issue from Modern Diagnostic & Research Centre, while 11 companies, including Gujarat Kidney & Super Speciality, are set to debut on the bourses.
Learn about spinning in IPOs, including its significance and ethical implications. Explore historical examples like Goldman Sachs and eBay's Meg Whitman.
Modern Diagnostic and Research Centre's IPO opens today, aiming to raise Rs 37 crore on the BSE SME platform, with early signals indicating a 12% premium.
Reviewing listing performances this year, Vinit Bolinjkar highlighted Meesho Ltd as one of the standout IPOs of 2025. In ...
Fintech IPO returned in 2025 as Circle, Chime, and Klarna raised $3.2B—marking a shift from hype to profitability.
MarketBeat on MSN
Why Baidu's quiet spin-off could unlock a major re-rating
After months of frustration and sideways trading, investors in Baidu (NASDAQ: BIDU) finally have a tangible reason to be ...
Learn what SEC Form F-1 is, its necessary criteria for foreign companies on U.S. exchanges, and explore detailed real-world filing examples for practical insight.
Structure Therapeutics Inc. (NASDAQ:GPCR) is a clinical stage global biopharmaceutical company that develops and delivers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback